Abstract: The rapid development of multi-omics data has provided new opportunities for cancer subtype classification. Due to the ability to model gene associations by constructing graph among genes, ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. In the United States and elsewhere, there’s been a major shift in ...
Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. If you watched the Super Bowl, you ...
Abstract: Obstructive Sleep Apnea (OSA) is a common respiratory disease characterized by recurrent airway block during sleep, which does great harm to the human body. Utilizing the ...
For decades, breast cancer screening has been synonymous with the mammogram. Women’s preventive care has centered on the annual test, and for good reason: 1 in 8 women in the United States are ...
The US Food and Drug Administration (FDA) has granted marketing clearance to Eyonis LCS, an artificial intelligence-powered software program to assist with lung cancer screening. The software was ...
Prostate cancer burden in 2026 is high, with disproportionate incidence and mortality in Black men and major survival decrements in distant-stage disease, supporting equitable, stage-shifting ...
from Hims & Hers is giving some medical experts pause. In addition to touting the company’s weight loss drugs and testosterone treatments, it promotes a controversial early cancer detection test.
It's quick and easy to access Live Science Plus, simply enter your email below. We'll send you a confirmation and sign you up for our daily newsletter, keeping you up to date with the latest science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results